Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis.
BBIBP-CorV
Multiple sclerosis
SARS-CoV-2, COVID-19 vaccines
adverse events
vaccine safety
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
31 12 2022
31 12 2022
Historique:
pubmed:
25
2
2022
medline:
15
4
2022
entrez:
24
2
2022
Statut:
ppublish
Résumé
To affirm the short-term safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among people with multiple sclerosis (pwMS), 517 vaccinated and 174 unvaccinated pwMS were interviewed. 16.2% of the vaccinated pwMS reported at least one neurological symptom in their respective vaccine-related at-risk periods (ARP) - a period from the first dose until two weeks after the second dose of the vaccine. In a multivariable logistic regression model, the presence of comorbidities (
Identifiants
pubmed: 35201963
doi: 10.1080/21645515.2022.2041945
pmc: PMC9009900
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2041945Références
Ther Adv Neurol Disord. 2021 Apr 22;14:17562864211012835
pubmed: 34035836
Arch Neurol. 2011 Oct;68(10):1267-71
pubmed: 21670384
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Mult Scler J Exp Transl Clin. 2021 Nov 29;7(4):20552173211061543
pubmed: 34868630
EBioMedicine. 2021 Oct;72:103581
pubmed: 34563483
EBioMedicine. 2022 Jun;80:104042
pubmed: 35526306
J Neurol. 2011 Jul;258(7):1197-206
pubmed: 21431896
CNS Neurosci Ther. 2019 Feb;25(2):245-254
pubmed: 30044050
Pract Neurol. 2020 Dec;20(6):435-445
pubmed: 32632038
J Neurol. 2017 Jun;264(6):1035-1050
pubmed: 27604618
Neurotherapeutics. 2022 Jan;19(1):325-333
pubmed: 34859382
JAMA. 2021 Jul 6;326(1):35-45
pubmed: 34037666
Vaccines (Basel). 2021 Jun 01;9(6):
pubmed: 34205917
Mult Scler. 2021 May;27(6):864-870
pubmed: 33856242
Mult Scler Relat Disord. 2021 Jul;52:102983
pubmed: 33990054
Neurol Sci. 2021 Sep;42(9):3523-3526
pubmed: 34128150
Mult Scler Relat Disord. 2021 Jul;52:103028
pubmed: 34049216
Lancet Infect Dis. 2021 Jan;21(1):39-51
pubmed: 33069281
Hum Vaccin Immunother. 2021 Oct 3;17(10):3481-3483
pubmed: 34015240
J Neurol Sci. 2014 Jun 15;341(1-2):22-7
pubmed: 24731783
Mult Scler Relat Disord. 2022 Jan;57:103417
pubmed: 34875487
Cell. 2020 Aug 6;182(3):713-721.e9
pubmed: 32778225
N Engl J Med. 2001 Feb 1;344(5):319-26
pubmed: 11172162
Eur J Neurol. 2021 Nov;28(11):3742-3748
pubmed: 34288285
Vaccines (Basel). 2021 Mar 04;9(3):
pubmed: 33806646
Vaccine. 2021 Oct 15;39(43):6347-6350
pubmed: 34579974
Eur J Neurol. 2018 Mar;25(3):527-534
pubmed: 29205701